These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 84854)

  • 1. Effect of trypsin and chymotrypsin on the polypeptides of large and small plaque variants of foot-and-mouth disease virus: relationship to specific antigenicity and infectivity.
    Moore DM; Cowan KM
    J Gen Virol; 1978 Dec; 41(3):549-62. PubMed ID: 84854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of trypsin treatment on the antigenic characteristics of plaque variants of type-O 1 and type Asia-1 foot-and-mouth disease viruses.
    Cowan KM; Erol N; Whiteland AP
    J Gen Virol; 1978 Nov; 41(2):437-42. PubMed ID: 82610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the minor polypeptides in the foot-and-mouth disease particle.
    Sangar DV; Rowlands DJ; Cavanagh D; Brown F
    J Gen Virol; 1976 Apr; 31(1):35-46. PubMed ID: 177728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic and cell attachment sites of FMDV: further evidence for their location in a single capsid polypeptide.
    Cavanagh D; Sangar DV; Rowlands DJ; Brown F
    J Gen Virol; 1977 Apr; 35(1):149-58. PubMed ID: 192841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of trypsin-sensitive antigenic determinants common to the intact virus particle and the 12S subunit of the Uga 6/70 strain of foot-and-mouth disease virus type SAT 2.
    Booth JC
    J Gen Virol; 1977 Mar; 34(3):551-5. PubMed ID: 67182
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation and characterization of trypsin-resistant O1 variants of foot-and-mouth disease virus.
    Barteling SJ; Meloen RH; Wagenaar F; Gielkens AL
    J Gen Virol; 1979 May; 43(2):383-93. PubMed ID: 225425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four independent antigenic determinants on the capsid polypeptides of aphthovirus.
    Haresnape JM; McCahon D
    J Gen Virol; 1983 Nov; 64 (Pt 11)():2345-55. PubMed ID: 6196438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
    Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
    Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of neutralizing antibodies and immunity in vaccinated guinea pigs by cyanogen bromide-peptides of VP3 of foot-and-mouth disease virus.
    Kaaden OR; Adam KH; Strohmeier K
    J Gen Virol; 1977 Feb; 34(2):397-400. PubMed ID: 65445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escape mutants of foot-and-mouth disease virus selected by monoclonal antibodies directed to a trypsin-sensitive neutralization epitope.
    Das BR; Pattnaik B; Venkataramanan R; Rai DV
    Acta Virol; 1997 Jun; 41(3):131-8. PubMed ID: 9385400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus.
    Bachrach HL; Moore DM; McKercher PD; Polatnick J
    J Immunol; 1975 Dec; 115(6):1636-41. PubMed ID: 171309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic enhancement of rotavirus infectivity: molecular mechanisms.
    Estes MK; Graham DY; Mason BB
    J Virol; 1981 Sep; 39(3):879-88. PubMed ID: 6270356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Location of an immunizing determinant within polypeptide VP1 of type O aphthovirus.
    Haresnape JM; King AM; McCahon D
    J Gen Virol; 1983 Nov; 64 (Pt 11)():2357-65. PubMed ID: 6196439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free translation of foot-and-mouth disease virus RNA into identifiable non-capsid and capsid proteins.
    Chatterjee NK; Polatnick J; Bachrach HL
    J Gen Virol; 1976 Sep; 32(3):383-94. PubMed ID: 61250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host cell selection of antigenic variants of foot-and-mouth disease virus.
    Bolwell C; Brown AL; Barnett PV; Campbell RO; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():45-57. PubMed ID: 2471782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus.
    Baxt B; Vakharia V; Moore DM; Franke AJ; Morgan DO
    J Virol; 1989 May; 63(5):2143-51. PubMed ID: 2467993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses.
    Meloen RH; Rowlands DJ; Brown F
    J Gen Virol; 1979 Dec; 45(3):761-3. PubMed ID: 94352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foot-and-mouth disease virus immunogenic capsid protein VPT: N-terminal sequences and immunogenic peptides obtained by CNBr and tryptic cleavages.
    Bachrach HL; Morgan DO; Moore DM
    Intervirology; 1979; 12(2):65-72. PubMed ID: 231585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitopes on foot-and-mouth disease virus particles. I. Topology.
    McCullough KC; Crowther JR; Carpenter WC; Brocchi E; Capucci L; De Simone F; Xie Q; McCahon D
    Virology; 1987 Apr; 157(2):516-25. PubMed ID: 2435060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of the trypsin-sensitive antigenic site of foot-and-mouth disease virus following direct binding to an ELISA plate.
    Pattnaik B; Venkataramanan R; Mukhopadhyaya AK
    J Immunol Methods; 1996 Jun; 192(1-2):195-7. PubMed ID: 8699018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.